Showing results 1 to 1 of 1
Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma Yoon, Dok Hyun; Koh, Youngil; Jung, Miyoung; Kwak, Jeong-Eun; Shin, Eui-Cheol; Hwang, Yu Kyeong; Kim, Won Seog, TRANSPLANTATION AND CELLULAR THERAPY, v.29, no.4, pp.253e1 - 253e9, 2023-04 |
Discover